Abstract
Aim:
To comparatively study the pharmacological profiles of 3-methyl-3-azabicyclo (3,3,1)nonanyl-9-α-yl-α-cyclopentyl-α-phenyl-α-glycolate (phencynonate hydrochloride, CPG), an anticholinergic agent, and its enantiomers [R(–)- and S(+)-CPG].
Methods:
The affinity and relative efficacy were tested using radioligand-binding assay with muscarinic acetylcholine receptors from rat cerebral cortex. The pharmacological activities were assessed in three individual experiments: (1) potentiating the effect of subthreshold hypnotic dose of sodium pentobarbital; (2) inhibiting oxotremorine-induced salivation; and (3) inhibiting the contractile response to carbachol.
Results:
The order of potency of phencynonate hydrochloride and its optical isomers to inhibit the binding of [3H]quinucli-dinyl benzilate ([3H]QNB) was R(–)-CPG (K i=46.49±1.27 nmol/L)>CPG (K i=271.37± 72.30 nmol/L)>S(+)-CPG (K i=1263.12±131.64 nmol/L). The results showed that R(–)-CPG had the highest affinity to central muscarinic receptors among the three compounds, but did not show any central depressant effects at dose from 10.00 to 29.15 mg/kg. CPG increased the effects of subthreshold hypnotic dose of sodium pentobarbital induced-sleeping [the ED50±95% LC value was 21.06±3.04 mg/kg]. CPG and R(–)-CPG displayed nearly equipotent effect in depressing oxotremorineinduced salivation [the ED50± 95% LC for R(–) and CPG were 1.10±0.28 and 1.07 ± 0.15 mg/kg, respectively], and the contractile response to carbachol (pA 2 values for R(–) and CPG were 6.84 and 6.80, respectively). S(+)-CPG presented the lowest anticholinergic profiles, but could potentate effects of its enantiomers in some manner.
Conclusions:
These data suggested that R(–)-CPG acted as an eutomer in racemate and a competitive antagonist to acetylcholine muscarinic receptors, but S(+)-CPG was less active in comparison to R(–)-CPG and its racemate. The central depressant effects of R(–)-CPG and S(+)-CPG were lower in comparison to its racemate.
Similar content being viewed by others
Article PDF
References
Ariens EJ, Wuis EW, Veringa EJ . Stereoselectivity of bioactive xenobiotics. A pre-Pasteur attitude in medicinal chemistry, pharmacokinetics and clinical pharmacology. Biochem Pharmacol 1988; 37: 9–18.
Birkett DJ . Racemates or enantiomers: regulatory approaches. Clin Exp Pharmacol Physiol 1989; 16: 479–83.
Ariens EJ . Stereochemistry: a source of problems in medicinal chemistry. Med Res Rev 1986; 6: 451–66.
Dai JG, Liu CG, Yu LS, Yang AZ, Jia HB, Wang KN . Antimotion sickness effect of phencynonate hydrochloride in man. Chin J Aerospace Med 1997; 8: 10–4.
Yamamura HI, Snyder SH . Muscarinic cholinergic binding in rat brain. Proc Natl Acad Sci USA 1974; 71: 1725–9.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ . Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–75.
Arunlakshana O, Schild HO . Some quantitative uses of drug antagonists. Br J Pharmacol 1959; 14: 48–58.
Cheng Y, Prusoff WH . Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 1973; 22: 3099–108.
Yates BJ, Miller AD, Lucot JB . Physiological basis and pharmacology of motion sickness: an update. Brain Res Bull 1998; 47: 395–406.
Kohl RL, Homick JL . Motion sickness: a modulatory role for the central cholinergic nervous system. Neurosci Biobehav Rev 1983; 7: 73–85.
Taillemite JP, Devaulx P, Bousquet F . Motion sickness. Med Trop 1997; 57: 483–7.
Deng YJ, Zhang YM . Study on the efficacy of phencynonate hydrochloride tablets in prevention of motion sickness. Chin J New Drugs 2001; 10: 453–4.
Nakamura T, Matsui M, Uchida K, Futatsugi A . M (3) muscarinic acetylcholine receptor plays a critical role in parasympathetic control of salivation in mice. J Physiol 2004; 558: 561–75.
Gautam D, Heard TS, Cui Y, Miller G, Miller G, Bloodworth L, Wess J . Cholinergic stimulation of salivary secretion studied with M1 and M3 muscarinic receptor single- and double-knock-out mice. Mol Pharmacol 2004; 66: 260–7.
Ehlert FJ, Thomas EA . Functional role of M2 muscarinic receptors in the guinea pig ileum. Life Sci 1995; 56: 965–71.
Honda K, Takano Y, Kamiya H . Pharmacological profiles of muscarinic receptors in the longitudinal smooth muscle of guinea pig ileum. Jpn J Pharmacol 1993; 62: 43–7.
Volpicelli LA, Levey AI . Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus. Prog Brain Res 2004; 145: 59–66.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the Major Program of National Natural Science Foundation of China (No 203900508).
Rights and permissions
About this article
Cite this article
Wang, Ly., Wang, Y., Zheng, Jq. et al. Pharmacological profiles of an anticholinergic agent, phencynonate hydrochloride, and its optical isomers. Acta Pharmacol Sin 26, 527–532 (2005). https://doi.org/10.1111/j.1745-7254.2005.00089.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2005.00089.x
Keywords
This article is cited by
-
Phencynonate S-isomer as a eutomer is a novel central anticholinergic drug for anti-motion sickness
Scientific Reports (2019)
-
Identification of In Vivo Metabolites of Levophencynonate in Human Plasma and Urine by High-Performance Liquid Chromatography Tandem Triple-Time-of-Flight Mass Spectrometry
Chromatographia (2017)